NewLink Genetics Corp (NASDAQ:NLNK)

4.54
Delayed Data
As of 4:00pm ET
 +0.05 / +1.11%
Today’s Change
3.75
Today|||52-Week Range
19.47
-44.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues172.6M68.5M35.8M28.7M
 
 
 
 
 
Depreciation And Amortization1.1M1.6M2.1M1.4M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses53.9M100.5M112.8M98.5M
 
 
 
 
 
Research And Development35.7M71.4M82.2M69.3M
 
 
 
 
 
Total Operating Expenses55.0M102.1M114.9M99.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income117.6M-33.6M-79.2M-71.2M
 
 
 
 
 
Extraordinary Charge--0.00-11.6M-1.7M
 
 
 
Interest Expense On Debt26.0K105.0K22.0K119.0K
 
 
 
 
 
Other Expenses0.00-14.0K32.0K-126.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income117.6M-33.6M-90.5M-72.5M
 
 
 
 
 
Income Taxes-14.8M-6.7M-5.4M-559.0K
 
 
 
 
 
Net Income102.9M-40.4M-85.2M-72.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.8M28.6M29.0M31.3M
 
 
 
 
 
Shares To Calculate EPS Diluted31.0M28.6M29.0M31.3M
 
 
 
 
 
 
Earnings Per ShareEPS$3.32-$1.41-$2.94-$2.30
 
 
 
 
 
EPS Diluted$3.32-$1.41-$2.94-$2.30